Novel Approaches to Behavioral Health Innovation Lecture Series
Overview
No field of medicine is in more dire need of new perspectives and new treatments than mental health. Despite the last 50 years seeing a proliferation of pharmacological and behavioral treatments, rates of mental illness—especially depression, anxiety, and substance abuse—continue to climb in the United States, with no strong evidence that our treatments are materially impacting these conditions on a society-wide level.
The ”Novel Approaches to Behavioral Health Innovation” Lecture Series seeks to address this mental health crisis head-on by providing fresh, scientifically-supported perspectives on mental illness. Importantly, these perspectives are far from merely theoretical. Rather, they provide a framework for understanding a range of new evidence-based treatments that, while not typically part of the clinician’s current toolbox, are in many cases are either already available or are about to be available for clinical use. In contrast to standard medication-based approaches to treating conditions such as depression and anxiety, the novel interventions explored in this lecture series approach emotional health in ways that leverage ecological and psychosocial understandings of wellbeing and that tap into evolved human capacities for strengthen psychological and physical resilience factors that are protective against mental illness.
Intended Audience
This activity is designed for Psychologists, Pharmacists and Pharmacy Technicians, Physicians, Nurses, Physician Assistants, Social Workers, and other behavioral health clinicians.
Learning Objectives
As a result of participation in this educational series, members of the healthcare team will be able to:
- Describe the scientific rationale behind adaptive stress based and related empirically supported interventions for depression, anxiety, substance use disorders, and related mental health conditions
- Plan and implement adaptive stress based and related empirically supported mental health interventions in clinical practice
- Describe and mange risks associated with adaptive stress based and related empirically supported mental health interventions
Faculty
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, committee members, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers/presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Casey Wolfington, PhD | Clinical Director/ Planning Committee Chair | No relevant relationships with ineligible companies to disclose | No |
Marshall Thomas, MD | Planner | No relevant relationships with ineligible companies to disclose | No |
Angelia Dreher, RPh, MBA | Planner | No relevant relationships with ineligible companies to disclose | No |
Whitney Georges, RN | Planner | No relevant relationships with ineligible companies to disclose | No |
Tracey Branch, MSW | Planner | No relevant relationships with ineligible companies to disclose | No |
Robert Brown, CPhT | Planner | No relevant relationships with ineligible companies to disclose | No |
Charles Raison, MD | Planner, Presenter | Otsuka America Pharmaceutical (Independent Contractor - Consultant), | No |
Tania Engle, PA | Planner | No relevant relationships with ineligible companies to disclose | No |
Accreditation
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and Vail Health. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
See individual sessions for credit designation.
Register/Enroll
Additional topics and dates coming soon!
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to help@icep.wisc.edu.
Accessibility
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu
Questions
For questions about registration, please email help@icep.wisc.edu. For general questions about this series, please contact Pam French at pamela.french@wisc.edu